MedFlowSoft specialises in software for the regulatory approval of medical devices, with an ambition to innovate the MedTech industry.

Supported by the Innovation Fund Denmark’s Innobooster programme, MedFlowSoft aims to develop an intelligent digital platform featuring an AI-powered assistant to help businesses navigate the international regulatory approval process for medical devices.

MedFlowSoft will ensure a fast, effective, and highly economical means of obtaining CE certification for medical devices—a process currently characterised by high expenses, long processing times, and significant risks of human error.

Today, many new medical devices are rejected by regulatory bodies due to technicalities that could have been easily avoided.

By leveraging state-of-the-art AI, MedFlowSoft provides MedTech companies with accurate assistance to streamline their navigation of the legislative landscape.

Their AI assistant will guide customers through content creation, document compilation, and deliverables, facilitating a smooth application process to notify the relevant regulatory bodies.

The end goal is to offer customers a faster and more cost-effective regulatory approval process for their medical devices, enabling new products to enter the market more quickly.